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Single-strain	outbreaks	of	Streptococcus pyogenes infections 
are	common	and	often	go	undetected.	In	2013,	two	clusters	
of	 invasive	 group	 A	 Streptococcus	 (iGAS)	 infection	 were	
identified	in	 independent	but	closely	 located	care	homes	in	
Oxfordshire,	 United	 Kingdom.	 Investigation	 included	 vis-
its	 to	 each	 home,	 chart	 review,	 staff	 survey,	 microbiologic	
sampling,	and	genome	sequencing.	S. pyogenes emm	type	
1.0,	the	most	common	circulating	type	nationally,	was	identi-
fied	 from	all	cases	yielding	GAS	 isolates.	A	 tailored	whole-
genome	 reference	 population	 comprising	 epidemiologically	
relevant	 contemporaneous	 isolates	 and	 published	 isolates	
was	 assembled.	 Data	 were	 analyzed	 independently	 using	
whole-genome	multilocus	sequencing	and	single-nucleotide	
polymorphism	analyses.	Six	isolates	from	staff	and	residents	
of	the	homes	formed	a	single	cluster	that	was	separated	from	
the	reference	population	by	both	analytical	approaches.	No	
further	cases	occurred	after	mass	chemoprophylaxis	and	en-
hanced	infection	control.	Our	findings	demonstrate	the	abil-
ity	of	2	independent	analytical	approaches	to	enable	robust	
conclusions	 from	 nonstandardized	 whole-genome	 analysis	
to	support	public	health	practice.
The reported annual incidence of invasive group A Strep-tococcus (iGAS) infection in industrialized countries 
is ≈3 cases per 100,000 persons per year (1–3). Incidence is 
3-fold higher among persons >70 years of age, particularly 
among the very elderly (1,2,4). Older persons have also 
been shown to have higher case-fatality rates, including 
in studies considering particular clinical syndromes, sug-
gesting that age is a risk for death independent of the 
clinical form of iGAS (1,5,6). Population-based study data 
estimate incidence among long-term care facility (LTCF) 
residents as 3.4-fold (7), 6.0-fold (8), and 7.8-fold (9) 
higher than that among elderly persons living outside insti-
tutional settings. Annual incidence estimates among LTCF 
residents range from 27 (7) to 74 (9) cases per 100,000 
persons. Case-fatality rates are also higher among LTCF 
residents (7–9).
Although iGAS mainly occurs sporadically, out-
breaks have been recognized in hospitals, particularly in 
association with surgery and maternity care (10,11), and 
in LTCFs, where they appear to be increasing (12,13). 
Many iGAS outbreaks go unidentified. Investigations that 
reviewed residents’ medical records in 7 LTCFs in which 
1 case of iGAS was reported identified missed outbreaks 
in 4 of the facilities (4). Furthermore, a surveillance study 
reported that LTCF staff members were unaware of hos-
pital-diagnosed iGAS among residents other than through 
study feedback (7). Three surveillance studies, including 2 
that used bacterial subtyping (7,8), identified iGAS clusters 
that had not been identified as outbreaks outside the sur-
veillance scheme (7–9). The delayed identification of out-
breaks in LTCFs (14,15) and clinical geriatric care settings 
(16,17) has also been described. Prospective surveillance in 
Ontario, Canada, identified 20 hospital outbreaks that were 
of smaller average size, often shorter duration, and more 
often outside the surgical and maternity settings than was 
expected based on findings in the nosocomial outbreak lit-
erature (10). Thus, sporadic disease may include many un-
identified small outbreaks. In an LTCF surveillance study 
(8), 40 of 383 isolates were members of 18 clusters of in-
distinguishable strains, and in another study (7), 34 of 134 
isolates were associated with 13 clusters, suggesting that 
10%–25% of culture-confirmed cases in LTCFs may be as-
sociated with outbreaks.
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SYNOPSIS
Genomic data are increasingly available to support the 
identification and investigation of outbreaks (18,19), in-
cluding 2 iGAS outbreaks associated with maternity units 
(20,21). In 1 of these studies, isolates collected on 2 con-
secutive days at a hospital were highly similar, and they 
were distinguishable from 2 other isolates of the same M 
protein gene (emm) type collected at a later date from 2 
other hospitals (21). In the second study (20), genome se-
quencing confirmed the relatedness of isolates from 2 pa-
tients on a maternity ward with fatal disease and isolates 
subsequently obtained from another patient, household 
contacts, and healthcare workers; the study also discrimi-
nated these isolates from 9 epidemiologically and geo-
graphically separated isolates of identical emm type. Ge-
nome sequencing may, therefore, separate Streptococcus 
pyogenes isolates with close epidemiologic relationships 
from the background population, as suggested from find-
ings from some other species of bacteria (19).
The purpose of this study was to integrate genomic 
data with other epidemiologic data in the investigation 
and control of a cross-institutional outbreak of S. pyogenes 
infection. We assessed approaches to enable robust infer-
ences in the absence of standard analytical methods.
Methods
We used standard epidemiologic and microbiologic ap-
proaches to investigate clusters of GAS infection in 2 man-
agerially independent but closely located LTCFs (home A 
and home B) in Oxfordshire, United Kingdom, in 2013. 
We also applied genomic sequencing to available isolates, 
analyzed the data using 2 independent approaches, and per-
formed a systematic literature review to describe evidence 
for the efficacy of different control strategies.
Literature Search
On February 21, 2014, we searched PubMed, using the 
terms: (“pyogenes” OR “group A streptococc*”) AND 
(“care” OR “nursing” OR “residential”) AND (“home” 
OR “homes” OR “facility” OR “facilities” OR “setting” 
OR “settings”). One author (N.D.M.) reviewed the 131 ab-
stracts retrieved by this search to identify those that referred 
to outbreaks or LTCFs (27 papers) and to population-level 
surveillance (3 papers). Identified papers were reviewed, 
references were searched for similar papers, and informa-
tion was extracted on the control methods used, outcomes, 
and whether reported outbreaks were each due to a single 
strain of S. pyogenes or involved multiple strains.
Epidemiologic Investigation of GAS Cases in LTCFs
We reviewed medical records for all possible cases of GAS 
infection among residents of the 2 LTCFs in 2013. In ad-
dition to cases already notified to public health authori-
ties, additional possible cases of GAS were identified for 
review through interviews by public health staff with se-
nior LTCF staff. Healthcare staff used case definitions from 
the UK national guidance (22) to assess residents or staff 
with symptoms suggestive of GAS infection. Clinically in-
dicated samples were obtained, as were skin and soft tissue 
infection samples and throat swab samples from residents 
or staff reporting sore throats. A web-based survey of staff 
enabled anonymous reporting of symptoms and infection-
control practices.
Microbiology
Samples from residents and staff were cultured to detect 
S. pyogenes using standard methods. The Public Health 
England National Streptococcal Reference Laboratory 
(Bacterial Reference Department) performed emm gene 
sequence typing on each isolate obtained as previously 
described (23,24) using DNA prepared by using the Wiz-
ard Genomic DNA Purification Kit (Promega, Madison, 
Wisconsin, USA); quality was determined by using a 
NanoDrop 2000 Spectrophotometer (Thermo Scientific, 
Waltham, MA, USA), and quantity was determined by 
using a Qubit 3.0 Fluorometer and quantitation assays 
(Thermo Fisher Scientific, Waltham, MA, USA). For se-
quencing preparation, we used a Nextera XT DNA Li-
brary Preparation Kit (Illumina, San Diego, CA, USA), 
and for sequencing, we used a HiSeq 2500 System (Illu-
mina) and the 2 × 100-bp paired-end mode. As a reference 
dataset to represent the background population, we used 
published genomes (20) and contemporaneous isolates of 
the same emm type from 3 clusters in other areas of the 
United Kingdom (Table).
Bioinformatic Processing
We used 2 independent approaches to process 39 genome 
sequences, of which 6 were for isolates from the LTCFs, 9 
were for isolates from contemporaneous confirmed cases, 
and 24 were published genomes (20). We used Burrows-
Wheeler Aligner software (http://bio-bwa.sourceforge.
net/) (25) to map reads to emm sequence type 1.0 (emm1) 
of S. pyogenes MGAS5505 (GenBank accession no. 
NC_007297-2). Single-nucleotide polymorphisms (SNPs) 
were discovered by using GATK2 software (Genome 
Analysis Toolkit v2) (26) and filtered by using the follow-
ing parameters: genotype quality >40, ratio of consensus/
nonconsensus base >0.8, distance to nearest SNP >15, 
root mean square of the mapping quality of the reads >50, 
number of reads with 0 mapping quality = 0. Reads were 
independently assembled by using the Velvet algorithm 
package (27), and loci were annotated with the genome 
annotation of S. pyogenes MGAS5005, which resulted in 
identification of 1,514 non-paralogous genetic loci with se-
quence data, enabling whole-genome multilocus sequence 
type (wgMLST) analysis (28).
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Bioinformatic Analysis
We constructed a maximum-likelihood phylogenetic tree 
by using RAxML (29), a multiple FASTA file of concat-
enated SNPs. We searched for 68 known superantigen and 
antimicrobial resistance genes, which were considered 
present if matches were found with >95% coverage and 
<10% SNPs difference from known variants.
We summarized allelic relationships by using the 
Genome Comparator tool within BIGSdb (30) and used 
pairwise differences to estimate a neighbor-joining tree by 
using MEGA5 software (31). The distribution of pairwise 
allelic differences among isolates was compared in each of 
3 categories: within the current suspected outbreak, within 
an outbreak reported by Turner et al. (20), and comparing 
the current suspected outbreak isolates with all other iso-
lates in the assembled dataset.
Results
Literature Review
Our literature review identified 72 LTCF-associated iGAS 
outbreaks from individual outbreak reports, summary data 
identified in surveillance studies, reviews, and laboratory 
studies (online Technical Appendix, http://wwwnc.cdc.gov/
EID/article/22/6/14-2050-Techapp1.pdf). These outbreaks 
included 31 clusters, which were defined as outbreaks on the 
basis of shared subtypes among >2 cases occurring at a fa-
cility within 1 year. Subtyping results were available for 22 
other outbreaks that were identified by other means. A single 
or dominant strain was identified for 19 of these outbreaks; 
multiple strains were reported for the other 3 outbreaks.
Interventions were varied but encompassed 3 broad 
approaches and showed limited evidence of different out-
comes. First, treatment restricted to patients with GAS 
or to patients with GAS and to their direct contacts with 
laboratory confirmed infection was associated with disease 
control in some outbreaks. However, in 1 outbreak, disease 
recurred after 2 rounds of this selective treatment, so mass 
chemoprophylaxis was administered within the LTCF. 
Second, in 2 reported outbreaks, all staff and residents were 
screened for GAS and if positive, they were offered chemo-
prophylaxis. This screening and treatment was associated 
with disease recurrence and repeated screening and treat-
ment. Additional cases of iGAS were diagnosed between 
decisions to screen and provide chemoprophylaxis and to 
actually implement chemoprophylaxis. Third, in all identi-
fied reports, chemoprophylactic treatment of all staff and 
residents was associated with control of iGAS, although in 
1 incident, persistent infection was shown in a resident who 
had a gastrostomy tube.
The literature review showed that screening detected 
carriage rates of <10% among LTCF residents, with 2 
exceptions, for which carriage rates were 20% and 16%. 
As previously described, carriage rates were lower among 
LTCF staff than residents (12,13).
Epidemiology of Cases in Home A and Home B
After 1 iGAS case each was identified in homes A and 
B, advice was given to the LTCF managers by Public 
Health England on infection control and how to identify 
other GAS-compatible infections in residents and staff. 
Although the 2 LTCFs were geographically close to each 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	6,	June	2016	 975
 
 
 
Table. Clinical	and	demographic	characteristics	of	patients	with	isolates	sequenced	in	a	study	integrating	genomic	and	other	
epidemiologic	data	to	investigate	and	control	a	cross-institutional	outbreak	of	Streptococcus pyogenes* 
Area,	laboratory	
no. Healthcare	setting Age/sex Source	of isolate Clinical	presentation Outcome 
1      
 H131441217 Care	home 95	y/F Blood	culture Bilateral	periorbital	cellulitis,	
sepsis 
Died 
 H131520646 Care	home 91	y/M Blood	culture Facial	cellulitis Died,	ANP 
 H131640460 Care	home 65	y/M Nasal	swab	sample Rash,	fever Recovered 
 H131620455 Care	home 84	y/F Arm	wound	swab	sample Arm	cellulitis Recovered 
 H131720333 Care	home 101	y/F Ear	swab	sample Weeping	ear Recovered 
 H132060515 Care	home	(CW) 19	y/F Throat	swab	sample Sore	throat Recovered 
2      
 H131280521 Care	home 94	y/F Blood	culture Severe	soft	tissue	infection Died 
 H131100707 Care	home 84	y/F Blood	culture Fever,	leg	cellulitis,	diarrhea,	
vomiting 
NR 
 H131220725 Care	home 93	y/F Blood	culture Fever,	severe	cellulitis Died 
 H131620436 Care home 78	y/F Blood	culture Emergency	room	admission NR 
 H131020872 Maternity	service 7	d/F Umbilical	wound	swab	
sample 
NR NR 
3      
 H131180727 Hospital 87	y/M Blood	culture NR NR 
 H130500483 Hospital 60	y/M Blood	culture Rash,	sepsis,	suspected	CAP NR 
4      
 H130620575 Hospital 39	y/M Pus	swab	sample NR NR 
 H130620574 Hospital 71	y/M Cannula	site	swab	sample NR NR 
*ANP,	acute	necrotizing	pneumonitis	diagnosed	postmortem;	CAP,	community-acquired	pneumonia;	CW,	care	worker,	NR	not	recorded. 
 
SYNOPSIS
other, neither home could initially identify any links with 
the other. Mass chemoprophylaxis was initiated at home A 
the day after a second case was reported and at home B af-
ter GAS (not iGAS) was confirmed in another resident who 
had cellulitis (Figure 1). Further investigation identified 3 
staff members who had worked in both of the managerially 
independent homes; 2 of these staff members had GAS-
compatible symptoms. Of 41 staff who responded to the 
anonymous survey, 38 identified their roles as a healthcare 
assistant (18 persons), cleaner (6 persons), manager or ad-
ministrator (6 persons), nurse (3 persons), or other (5 per-
sons). One respondent reported working at both homes, and 
1 reported working at home B and in the community. Of the 
41 respondents, 32 reported no symptoms, 7 reported sore 
throats, 1 reported a rash on the neck, and 1 reported illness 
without specifying symptoms.
Twelve possible GAS infections were not confirmed 
by culture. One of the infections was on the scalp of a 
resident at home A; the patient, who had a temperature 
>39°C and hallucinations, was treated with antimicrobial 
drugs and tested negative on subsequent samples. Another 
possible infection was on the eyelid of a resident at home 
B. Eight possible infections were in persons who worked 
at home A and who reported symptoms consistent with 
pharyngitis; 1 of the 8 staff members also worked at home 
B. Another person who worked at both LTCFs reported 
having paronychia that was treated with antimicrobial 
drugs, and 1 staff member at home B reported a recurrent 
skin infection.
Microbiology
S. pyogenes isolates were obtained from 6 of 13 speci-
mens from symptomatic residents and staff at homes A 
and B. Two patients in home A, 1 of whom died, had S. 
pyogenes–positive blood cultures and facial cellulitis. 
One patient in home B had periorbital cellulitis and GAS 
bacteremia. Two other patients in home B had confirmed 
GAS; 1 of these patients had cellulitis and systemic symp-
toms, including fever, but no sample from a normally 
sterile site, and the other patient had an outer ear infec-
tion. One staff member working in both institutions had 
GAS pharyngitis.
Isolate Relatedness, Antimicrobial Resistance,  
and Virulence Genes
All 6 isolates from the cross-institutional S. pyogenes out-
break were T-type 1 (phenotypic typing), emm1, and sic 
(streptococcal inhibitor of complement gene) sequence 
type 1.02. Nine isolates from 3 contemporaneous puta-
tive clusters in the United Kingdom were available for 
comparison. Whole-genome sequencing yielded, on aver-
age, 85-fold depth for these 15 isolates. All shared 7-lo-
cus MLST sequence type 28 with 24 published genomes 
from the United Kingdom (20). Analysis of all 39 genomes 
against the S. pyogenes MGAS5005 genome demonstrated 
334 SNPs. Separation of the isolates from the cross-insti-
tutional S. pyogenes outbreak from all other analyzed iso-
lates was strongly supported (98% bootstrap value). Iso-
lates from the staff member and 3 residents of the 2 homes 
were positioned in the same monophylogenetic clade and, 
in each case, differed from the isolates from the remaining 
2 infected residents by a single SNP (Figure 2). Gene-by-
gene analysis (wgMLST) also clustered the LTCF outbreak 
(Figure 2). The 6 isolates showed pairwise differences from 
each other at 1–9 (median 4) of the 1,514 loci and pair-
wise differences from all other isolates at >13 (median 37) 
loci (Figure 3). The outbreak reported by Turner et al. (20) 
showed similar within-outbreak pairwise differences at 0–9 
(median 5) loci. Putative contemporaneous clusters X and 
Y were also supported by genome sequencing.
We determined the presence or absence of 68 viru-
lence or antimicrobial drug–resistance–associated genes 
in the genomes sequenced for this study (online Techni-
cal Appendix Table). With the following exceptions, all 
isolates had the same genotype: speC was present only in 
isolates Y1 and Y2 (Figure 2), MF4 was present only in 
isolate TR7, and spd3 and spy1438 were present in all iso-
lates except TR7. This varied presence of these 4 bacterio-
phage-associated genes may reflect phage mobility within 
S. pyogenes (32). Genes and mutations associated with 
macrolide and tetracycline resistance (homologs of mefA, 
tetM, and tetO) and fluoroquinolone-resistance mutations 
(in genes parC and gyrA) were not found in compari-
son with the fluoroquinolone-susceptible reference strain 
ATCC700294 (GenBank accession no. AF220946.1); 
976	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	6,	June	2016
Figure 1.	Onset	dates	of	group	
A Streptococcus infection in 
2	long-term	care	facilities	in	
Oxfordshire,	United	Kingdom,	
2013.	Arrows	indicate	initiation	of	
chemoprophylaxis;	S,	staff;	 
R,	resident;	*	indicates	staff	 
who	worked	in	both	homes.	 
Dark	gray	shading	indicates	
laboratory-confirmed	infections;	
light	gray	shading	indicates	
nonconfirmed	infections.
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however, a nonsynonymous SNP (T2393C) of the parC 
gene was identified in all strains. Mutations in covR/S (the 
S. pyogenes regulatory system), which are reported to be 
associated with strain hyperinvasiveness, were seen in all 
15 isolates, in common with strain MGAS5005. No unique 
mutations were identified in any of the isolates.
Discussion
We have described an iGAS outbreak across 2 manageri-
ally independent LTCFs, in which some staff worked in 
both facilities on separate employment contracts. Cluster-
ing in the temporal and genomic dimensions supported 
GAS transmission within and between these settings. 
Shared staff across care settings without managerial aware-
ness may be common in this sector, in which low pay and 
part-time working patterns are common. Loss of pay while 
absent from work has been recognized as a risk factor in 
LTCF outbreaks (33,34). Loss of pay when excluded from 
work in 1 setting may also contribute to spread of infection 
to other settings, unless staff members understand that this 
exclusion applies to similar work in other settings and com-
ply with the exclusion from work in all settings.
We found 1 other report of an iGAS outbreak across 2 
LTCFs; the article explored the use of subtyping but did not 
include epidemiologic details of the outbreak (35). Spread 
of infection between institutions, resulting in apparently 
sporadic cases or small outbreaks in each, may be difficult 
to identify as a single outbreak. Our genomic data, triangu-
lated with other descriptive epidemiologic data, supported 
our conclusion that this was a single outbreak. However, 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	6,	June	2016	 977
Figure 2.	Genetic	relatedness	of	isolates	from	a	cross-institutional	Streptococcus pyogenes	outbreak	in	Oxfordshire,	United	Kingdom	
(indicated	by	TV	plus	isolate	number);	an	outbreak	described	by	Turner	et	al.	(20)	(indicated	by	TR	and	TO	plus	isolate	number	for	
reference	and	outbreak	isolates,	respectively);	and	3	geographic	outbreak	clusters	in	the	United	Kingdom	around	the	time	of	the	
TV	outbreak	(indicated	by	X,	Y,	or	Z	plus	isolate	number).	Dendrograms	are	based	on	a	single-nucleotide	polymorphism	maximum-
likelihood	phylogenetic	tree	constructed	by	using	RAxML	(29)	(A)	and	on	a	neighbor-joining	tree	constructed	from	the	allelic	differences	
distance	matrix	(B).	Scale	bars	indicate	10	single-nucleotide	polymorphism	differences	(A)	and	15	allelic	differences	(B).
SYNOPSIS
the application of these techniques is relatively untried: 
neither standardized methods nor extensive national, ge-
nome-sequenced reference populations are in place for S. 
pyogenes, and the population biology of this species at the 
whole-genome level is not fully described.
We dealt with the lack of an established analytical 
method, which would confirm that isolates are part of a 
single outbreak, and uncertain S. pyogenes population ge-
nomics by using 2 types of analyses (i.e., whole-genome 
multilocus sequence and single-nucleotide polymorphism 
analyses) and bioinformatics pipelines that did not rely on 
shared assumptions about the population biology of this 
species. The identification of core SNPs from a reference-
based assembly, exclusion of SNPs that are nearby to avoid 
an excessive effect from single recombination events, and 
subsequent generation of an SNP-based phylogeny echo the 
techniques used in other analyses of this species (20,21). 
In our analysis of wgMLST data, we used a reference-free 
assembly method and assessed the number of shared and 
discordant alleles across the dataset without making as-
sumptions on processes giving rise to allelic variation (28). 
The replication of clustering by different and independent 
approaches adds credibility to the epidemiologic inferences 
drawn. In the absence of extensive genome-sequenced ref-
erence populations relevant to the incident under investi-
gation, we used a set of isolates that were identical to the 
isolates of interest by conventional emm sequence typing 
methods (36); some of the isolates from this set were also 
from the same time period and country as the isolates of 
interest. Discriminating isolates from other isolates of the 
same emm type can thus demonstrate discrimination from 
the population of S. pyogenes strains as a whole and support 
outbreak management when appropriate population-based, 
genome-sequenced reference datasets are unavailable.
Each approach clearly identified the outbreak cluster 
and differentiated the isolates in this outbreak from other 
contemporaneous isolates within the same emm gene se-
quence type (emm1) and MLST type, similar to findings 
by Turner et al. (20). SNP analysis indicated isolates from 
homes A and B were separated from all other clades by at 
least 14 SNPs, but they differed from each other by a maxi-
mum of 2 SNPs. Gene-by-gene analysis showed a median 
of 4 allelic differences in pairwise comparisons within the 
outbreak across 1,514 genetic loci; this finding contrasts 
with a median of 37 allelic differences between isolates 
from the current outbreak and 33 other genomes of the same 
emm type. Gene-by-gene analysis of data from the outbreak 
reported by Turner et al. (20) showed almost identical with-
in-outbreak variation (median of 5 differences, range 0–9) 
(Figure 3). Thus a similar amount of allelic variation was 
present in the cross-institutional cluster and the cluster re-
ported by Turner et al. (20). These findings contrast with 
much greater variation when compared with other isolates 
from the same emm type. These 2 incidents had epidemio-
logic data indicating likely transmission over a period of 
days to a few weeks. This range of variation may therefore 
be an estimate for expected variation in the transmission 
systems generating small, short-lived GAS outbreaks.
Additional well-characterized outbreaks with genome-
sequenced isolates will enable fuller empirical validation of 
these results. More long-lived outbreaks may be associated 
with greater variation, and, indeed, multistrain streptococ-
cal outbreaks can arise where a mobile genetic element can 
support the increase of several pathogenic lineages acquir-
ing it (37). In contrast to the clear and similar discrimination 
of the cross-institutional outbreak isolates from other emm1 
isolates by each analytical approach, no marked structure 
was shown by either analysis among the outbreak isolates. 
The limited extent of evolution occurring, as indexed and 
analyzed by our approaches across the available genome, 
does not enable inference on particular transmission path-
ways within this short-lived, single-clone outbreak.
Our literature review showed that most reported LTCF 
iGAS outbreaks have been caused by a single strain, and 
many outbreaks go unrecognized. The use of genome se-
quence analysis may distinguish epidemiologic clusters 
from background isolates, enabling detection of a large pro-
portion of currently missed LTCF outbreaks. Given litera-
ture-based estimates that 10%–25% of apparently sporadic 
iGAS cases in LTCFs may belong to outbreaks (7,8), the 
integration of genome sequencing into iGAS surveillance 
in this population might be justified by this purpose alone. 
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Figure 3.	Pairwise	allelic	differences	(across	1,514	genetic	loci)	
among	6	isolates	from	a	cross-institutional	Streptococcus pyogenes 
outbreak	in	Oxfordshire,	United	Kingdom,	and	other	isolates.	Green	
indicates	differences	between	each	of	the	6	Oxfordshire	outbreak	
isolates	and	each	of	the	other	33	isolates	that	occurred	in	other	
geographic	areas	in	the	United	Kingdom	around	the	time	of	the	
Oxfordshire	outbreak	or	were	reported	by	Turner	et	al.	in	2013	
(20).	Red	indicates	differences	between	outbreak	isolates	from	the	
cluster	described	by	Turner	et	al.	(20).	Blue	indicates	differences	
between	each	isolate	in	the	Oxfordshire	outbreak	compared	with	
each	of	the	other	5	isolates	in	the	outbreak.
Integration	of	Data	to	Investigate	S. pyogenes
Detection of missed outbreaks may enable identification 
of risk factors that contribute to the outbreaks. Genomic 
surveillance could also support detection and investigation 
of transmission events between LTCFs and other settings. 
The relatively low population-level incidence of iGAS 
(1–3) may make genome sequence surveillance financially 
feasible in countries that have microbiologic iGAS surveil-
lance systems in place.
This outbreak was controlled after use of mass che-
moprophylaxis and standard infection-control measures. 
Infection-control measures are widely reported as part of 
iGAS outbreak control methods; chemoprophylaxis shows 
more variation. There was, on average, better control in out-
breaks in which mass chemoprophylaxis was undertaken, 
and there were reports of further cases during the wait for 
screening test results (38,39). However, the evidence base 
is limited and carriage rates are low among residents and 
staff (12,13), and some argue that mass chemoprophylaxis 
is inappropriate (40). The ability to identify large numbers 
of outbreaks early, as appears possible by genomic surveil-
lance, may offer a sampling frame to generate more reliable 
data for the role of chemoprophylaxis by analyzing out-
comes across a large number of outbreaks by the approach 
used or through trials of different approaches.
In summary, we investigated an iGAS outbreak in 2 
institutions by integrating pathogen genomic epidemiology 
to infer epidemiologic relatedness. Independent bioinfor-
matic and population genetic approaches enabled credible 
conclusions in the absence of a standardized approach. The 
excess burden of iGAS among elderly residents of LTCFs, 
the large proportion of cases that are associated with un-
detected outbreaks, and the consequent opportunity to im-
prove the evidence base for control support consideration 
of genomic surveillance of iGAS.
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